Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...

Vertice has made a name for itself over the years in the crowded world of expenditure management by focusing on applying AI to optimize an area where businesses are sinking hundreds of billions of ...

Lakestar leads round with participation from existing investors Bessemer Venture Partners and 83North LONDON and NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Vertice, the spend optimization platform ...

Watch as Lewis Hamilton has first test in Ferrari F1 car Lewis Hamilton said his first test in a Ferrari Formula 1 car was "awe-inspiring" and "one of the best feelings of my life". The 40-year ...

Vertice's Series C funding aims to enhance procurement with innovative tech across global markets Spend optimisation platform Vertice recently celebrates a significant financial boost, securing US$50m ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...

As you prepare for JEE 2025, revising important formulas is crucial to performing well in the exam. The JEE syllabus covers a vast array of topics in Physics, Chemistry, and Mathematics, and being ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.